Total Payments
$5,263
2024 Payments
$79.74
Companies
31
Transactions
342
Medicare Patients
4,026
Medicare Billing
$234,761
Payment Breakdown by Category
Food & Beverage$5,155 (98.0%)
Education$107.60 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,155 | 340 | 98.0% |
| Education | $107.60 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,507 | 119 | $0 (2023) |
| Amarin Pharma Inc. | $595.88 | 28 | $0 (2023) |
| Lilly USA, LLC | $500.75 | 40 | $0 (2023) |
| Astellas Pharma US Inc | $452.43 | 24 | $0 (2023) |
| ABBVIE INC. | $442.80 | 28 | $0 (2024) |
| Amgen Inc. | $331.30 | 24 | $0 (2023) |
| Dexcom, Inc. | $183.83 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $137.48 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $136.41 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $125.30 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.74 | 3 | Dexcom, Inc. ($64.69) |
| 2023 | $1,378 | 86 | Novo Nordisk Inc ($389.33) |
| 2022 | $1,637 | 107 | Novo Nordisk Inc ($489.81) |
| 2021 | $2,168 | 146 | Novo Nordisk Inc ($627.93) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: Endocrinology | ||||||
| 02/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: Endocrinology | ||||||
| 12/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes Care | ||||||
| 11/07/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Endocrinology | ||||||
| 10/13/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes Care | ||||||
| 09/22/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Bone Health | ||||||
| 09/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Diabetes | ||||||
| 09/15/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Biological | ||||||
| 09/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes | ||||||
| 09/05/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Endocrinology | ||||||
| 08/31/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Bone Health | ||||||
| 08/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Diabetes | ||||||
| 08/07/2023 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 07/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: Diabetes | ||||||
| 07/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Biological | ||||||
| 06/29/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 681 | 777 | $110,529 | $39,474 |
| 2022 | 11 | 1,105 | 1,391 | $165,534 | $68,577 |
| 2021 | 12 | 1,258 | 1,625 | $184,455 | $79,105 |
| 2020 | 13 | 982 | 1,210 | $120,472 | $47,606 |
Total Patients
4,026
Total Services
5,003
Medicare Billing
$234,761
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 277 | $54,015 | $18,024 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 222 | $30,414 | $11,463 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $10,621 | $3,970 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $9,558 | $3,630 | 38.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 34 | 36 | $2,592 | $1,246 | 48.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 15 | $1,470 | $409.28 | 27.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 54 | 61 | $427.00 | $208.01 | 48.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 12 | $396.00 | $194.64 | 49.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 24 | $672.00 | $186.60 | 27.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 28 | $364.00 | $141.93 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 328 | 398 | $77,515 | $31,952 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 366 | 448 | $61,376 | $24,587 | 40.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 122 | 138 | $9,936 | $5,885 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,446 | $1,922 | 43.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $5,878 | $1,789 | 30.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 46 | 48 | $1,584 | $784.99 | 49.6% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 20 | 21 | $2,058 | $623.53 | 30.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 51 | $1,428 | $467.86 | 32.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 80 | 95 | $665.00 | $323.90 | 48.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 23 | 42 | $546.00 | $194.80 | 35.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 25 | 102 | $102.00 | $47.43 | 46.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 332 | 399 | $77,805 | $33,548 | 43.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 439 | 545 | $74,665 | $30,867 | 41.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 127 | 140 | $10,080 | $6,332 | 62.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $5,928 | $2,441 | 41.2% |
About Tamara Meligan, PAC
Tamara Meligan, PAC is a Physician Assistant healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1447543608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tamara Meligan, PAC has received a total of $5,263 in payments from pharmaceutical and medical device companies, with $79.74 received in 2024. These payments were reported across 342 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,155).
As a Medicare-enrolled provider, Meligan has provided services to 4,026 Medicare beneficiaries, totaling 5,003 services with total Medicare billing of $234,761. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Pensacola, FL
- Active Since 05/20/2011
- Last Updated 03/16/2016
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1447543608
Products in Payments
- Ozempic (Drug) $681.33
- Vascepa (Drug) $595.88
- Rybelsus (Drug) $438.69
- TRULICITY (Drug) $276.91
- EVENITY (Biological) $248.48
- Dexcom G6 Transmitter (Medical Supply) $183.83
- MYRBETRIQ (Drug) $176.10
- NURTEC ODT (Drug) $168.13
- UBRELVY (Drug) $163.14
- Myrbetriq (Drug) $141.59
- FARXIGA (Drug) $125.30
- VRAYLAR (Drug) $122.75
- MOUNJARO (Drug) $108.89
- JARDIANCE (Drug) $108.59
- RYBELSUS (Drug) $102.38
- VYVANSE (Drug) $98.85
- EMGALITY (Drug) $89.92
- ELIQUIS (Drug) $82.17
- TRELEGY ELLIPTA (Drug) $75.66
- Wegovy (Drug) $75.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pensacola
Christopher Smith, Pa-C, PA-C
Physician Assistant — Payments: $68,297
Physician Assistant $68,297
Jordan Peacock, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $15,778
Physician Assistant $15,778
Amanda Bear, Pa-C, PA-C
Physician Assistant — Payments: $15,224
Physician Assistant $15,224
Jenna Simon, Pa-C, PA-C
Physician Assistant — Payments: $8,514
Physician Assistant $8,514
Mrs. Shelby Richardson, Pa-C, PA-C
Physician Assistant — Payments: $8,003
Physician Assistant $8,003
Melissa Robertson, Pa, PA
Physician Assistant — Payments: $7,507
Physician Assistant $7,507